These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Treatment of gastro-oesophageal reflux and gastric stasis: new perspectives with cisapride. Proceedings of a symposium of the 13th International Congress of Gastroenterology. Rome, 6 September 1988. Scand J Gastroenterol Suppl; 1989; 165():1-65. PubMed ID: 2602909 [No Abstract] [Full Text] [Related]
46. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride. De Nutte N; Van Ganse W; Witterhulghe M; Defrance P Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906 [TBL] [Abstract][Full Text] [Related]
47. Cisapride and cystic fibrosis. Santamaria F; Oggero V; Raia V; Salvatore D; Vittoria L; de Ritis G J Pediatr Gastroenterol Nutr; 1989 Nov; 9(4):539. PubMed ID: 2621534 [No Abstract] [Full Text] [Related]
48. Comparing the efficacy of cisapride and ranitidine in oesophagitis: a double-blind, parallel group study in general practice. Dakkak M; Jones BP; Scott MG; Tooley PJ; Bennett JR Br J Clin Pract; 1994; 48(1):10-4. PubMed ID: 8179973 [TBL] [Abstract][Full Text] [Related]
49. Cisapride improves gallbladder kinetics in patients affected with myotonic muscular dystrophy. Marchi S; Polloni A; Bellini M; Orsitto E; Costa F; Spataro M; Rossi B; Siciliano G; Masi MC; Tumino E Int J Clin Pharmacol Res; 1993; 13(1):53-8. PubMed ID: 8509236 [TBL] [Abstract][Full Text] [Related]
51. [Cisapride: clinical experience in 1071 patients with non-ulcer dyspepsia or reflux symptoms]. Fehr HF Schweiz Med Wochenschr; 1991 Jun; 121(22):843-6. PubMed ID: 2063165 [TBL] [Abstract][Full Text] [Related]
52. Influence of cisapride on food-stimulated gastro-oesophageal reflux: a radiological study. Gelineck J; Aksglade K; Funch-Jensen P; Thommesen P Rontgenblatter; 1990 Aug; 43(8):352-4. PubMed ID: 2204995 [TBL] [Abstract][Full Text] [Related]
53. Effect of cisapride and cimetidine on 24-hour intraesophageal pH monitoring in patients with gastroesophageal reflux disease. Chojnacki J; Tkaczewski W; Wichan P; Grzegorczyk K; Klupińska G Mater Med Pol; 1992; 24(3):196-8. PubMed ID: 1307654 [TBL] [Abstract][Full Text] [Related]
54. [Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis]. Scalon P; Di Mario F; Meggiato T; Basso D; Battaglia G; Vianello F; Fogar P; Del Favero G Minerva Gastroenterol Dietol; 1992; 38(2):101-4. PubMed ID: 1391144 [TBL] [Abstract][Full Text] [Related]
55. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents. McCallum RW Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702 [TBL] [Abstract][Full Text] [Related]
56. Gastrointestinal transit after spinal cord injury: effect of cisapride. Rajendran SK; Reiser JR; Bauman W; Zhang RL; Gordon SK; Korsten MA Am J Gastroenterol; 1992 Nov; 87(11):1614-7. PubMed ID: 1442685 [TBL] [Abstract][Full Text] [Related]
57. Effects of cisapride on anorectal and vesicourethral function in spinal cord injured patients. Carone R; Vercelli D; Bertapelle P Paraplegia; 1993 Feb; 31(2):125-7. PubMed ID: 8446457 [TBL] [Abstract][Full Text] [Related]
58. [Hepatitis and pancreatitis due to indalpine]. Calmus Y; Biour M; Bodin F; Cheymol G; Darnis F Gastroenterol Clin Biol; 1985 Mar; 9(3):266-8. PubMed ID: 4007381 [TBL] [Abstract][Full Text] [Related]